Danaher

Danaher Corporation (NYSE: DHR) is a leading global life sciences and diagnostics innovator headquartered in Washington, DC Founded in 1984 by brothers Steven and Mitchell Rales, Danaher has evolved from its origins as a real estate investment trust into a diversified science and technology company focused on improving human health.

Danaher's portfolio comprises over 15 operating companies across three main segments:

• Life Sciences: Provides tools and services for biological research and biopharmaceutical manufacturing. Key brands include Cytiva, Pall Corporation, Beckman Coulter Life Sciences, and Leica Microsystems.

• Diagnostics: Offers clinical diagnostic instruments and tests. Major businesses include Beckman Coulter Diagnostics, Radiometer, and Cepheid.

• Environmental & Applied Solutions: Provides water quality analysis and treatment solutions as well as product identification technologies. Notable brands include Hach, ChemTreat, and Videojet.

Danaher utilizes its proprietary Danaher Business System (DBS) to drive continuous improvement and innovation across its portfolio. The company has a strong track record of growth through strategic acquisitions, having completed over 400 acquisitions since 1984. Recent major acquisitions include Cytiva (formerly GE Biopharma) in 2020 and Aldevron in 2021.

For the full year 2023, Danaher reported revenues of USD 23.9 billion and adjusted earnings per share of USD 7.58. The company employs approximately 63,000 associates worldwide. Danaher continues to focus on expanding its capabilities in high-growth markets like genomics, bioproduction, and diagnostics to accelerate scientific and technological innovation in healthcare.